Loading…
ITK Inhibitor Induces Dose-Dependent Th1 Skewing in Normal T Cells and Is Active in Refractory T Cell Lymphomas
Saved in:
Published in: | Blood 2022-11, Vol.140 (Supplement 1), p.8857-8859 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 0006-4971 1528-0020 |
DOI: | 10.1182/blood-2022-159177 |